Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AstraZeneca ADR | AZN | Sep 19, 2024 | 78.90 | +0.41 |
Astria Therapeutics | ATXS | Sep 19, 2024 | 12.35 | +6.37 |
Astronics | ATRO | Sep 19, 2024 | 20.70 | +3.60 |
AstroNova | ALOT | Sep 19, 2024 | 14.18 | +4.73 |
Astrotech | ASTC | Sep 19, 2024 | 8.22 | -0.24 |
Asure Software | ASUR | Sep 19, 2024 | 9.19 | +0.99 |
AT&T | T | Sep 19, 2024 | 21.36 | -1.70 |
AT&T A Pref | T-A | Sep 19, 2024 | 22.59 | +0.98 |
AT&T C Pref | T-C | Sep 19, 2024 | 21.50 | +0.70 |
ATA Creativity Global ADR | AACG | Sep 19, 2024 | 0.53 | +2.18 |
Atai Life Sciences BV | ATAI | Sep 19, 2024 | 1.26 | +1.61 |
Atara Biotherapeutics | ATRA | Sep 19, 2024 | 7.93 | +0.76 |
Atea Pharmaceuticals | AVIR | Sep 19, 2024 | 3.82 | -4.26 |
Aterian | ATER | Sep 19, 2024 | 3.24 | +0.93 |
Athena Technology Acquisition II | ATEK | Sep 19, 2024 | 11.51 | -5.66 |
Athene A Pref | ATH-A | Sep 19, 2024 | 25.30 | +1.16 |
Athene B Pref | ATH-B | Sep 19, 2024 | 22.67 | +1.25 |
Athene C Pref | ATH-C | Sep 19, 2024 | 25.40 | +1.44 |
Athene D Pref | ATH-D | Sep 19, 2024 | 19.46 | +0.62 |
Athene Holding | ATH-E | Sep 19, 2024 | 26.50 | +0.76 |
Athira Pharma | ATHA | Sep 19, 2024 | 0.46 | +0.41 |
Ati Physical Therapy A | ATIP | Sep 19, 2024 | 5.67 | +1.34 |
ATIF Holdings | ATIF | Sep 19, 2024 | 1.05 | +0.07 |
Atkore | ATKR | Sep 19, 2024 | 89.16 | +2.88 |
Atlanta Braves A | BATRA | Sep 19, 2024 | 44.20 | +0.59 |
Atlanta Braves C | BATRK | Sep 19, 2024 | 41.64 | +1.41 |
Atlantic American | AAME | Sep 19, 2024 | 1.64 | +5.48 |
Atlantic Coastal Acquisition II A | ACAB | Sep 19, 2024 | 11.32 | +0.62 |
Atlantic Union Bank | AUB | Sep 19, 2024 | 39.35 | +2.66 |
Atlantic Union Bankshares A Pref | AUB-A | Sep 19, 2024 | 24.31 | -0.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.